BRIDGEBIO ONCOLOGY THERAPEUT
BBOT·107924102·US·Common Stock·Healthcare - Biotechnology-Activist
BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) is held by 39 institutional investors as of Q1 2026. Largest holders: Alphabet Inc. ($25.3M), WELLINGTON MANAGEMENT GROUP LLP ($25.2M), CITADEL ADVISORS LLC ($22.6M). Net institutional sentiment: Bullish.
39
Holders
Avg rating(4 Elite)
$143.3M
Total Value
74% (41)
Fund Consensus
26 buying - 9 selling
Who's Trading
ActivistBCBihua Chen22.3%Jul 6, 2026
InsiderBYBen YongTax 1K shApr 1, 2026
InsiderBPBeltran PedroTax 1K shApr 1, 2026
InsiderMUMehra UneekTax 524 shApr 1, 2026
ActivistADAdage Capital Management, L.P.1.9%Nov 13, 2025
ActivistBGBC Global Opportunities IX LP5.5%Sep 3, 2025
ActivistDMDeerfield Mgmt, L.P.3.1%Aug 18, 2025
ActivistBPBridgeBio Pharma LLC17.5%Aug 18, 2025
13F: Insider & Congress:
Showing 1-20 of 41
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer